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Abstract: Zingerone (1) and both chiral forms of zingerol (2) were obtained from 
dehydrozingerone (3) by biotransformation with filamentous fungi. The bioconversion of 3 
with A. fumigatus, G. candidum or R. oryzae allowed the production of 1 as the sole 
product at 8 h and in 81%–90% at 72 h. In turn, A. flavus, A. niger, C. echinulata,  
M. circinelloides and P. citrinum produced 1 at 8 h, but at 72 h alcohol 2 was obtained as 
the major product (74%–99%). Among them, A. niger and M. circinelloides led to the  
anti-Prelog zingerol (R)-2 in only one step with high conversion rates and ee. Instead,  
C. echinulata and P. citrinum allowed to obtain (S)-2 in only one step, with high conversion 
rates and ee. Both chiral forms of 2 were tested for antifungal properties against a panel of 
clinically important fungi, showing that (R)-, but not (S)-2 possessed antifungal activity. 
Keywords: zingerone; chiral zingerols; filamentous fungi; enantioselective bioconversions; 
green chemistry; antifungal 
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1. Introduction 
Nearly 80% of all available flavoring agents used worldwide are produced by chemical synthesis [1]. 
However there is an increasing preference of the consumer for “natural” food additives all over the 
world, mainly due to increasing health and nutrition conscious lifestyles [2]. This trend is reflected  
in European and US legislations [3] that clearly discriminate between natural or synthetic  
(natural-identical) flavors, turning the interest of industries to the production of natural flavors.  
In addition, these legislations consider that the strategy of production of flavors by microbial processes 
(namely white biotechnology or green chemistry) can be labeled as “natural” [4]. 
Zingerone [4-(3-methoxy-4-hydroxyphenyl)-butan-2-one] CAS#122-48-5 (1) is the least pungent 
component of Zingiber officinale Rosc. [5,6] that provides the typical ginger sweet spicy aroma [7] 
and is used as a flavoring agent in the food industry. Simultaneously it also minimizes the lipid 
oxidation of food, which strongly suggests that 1 can be used as an antioxidant and food preservative [8]. 
This phenolic alkanone is also present in wines at very low concentrations (0.74–8.94 × 10−3 µg/mL) [9]. 
In addition to the applications as a food additive, 1 possesses several pharmacological effects, such as 
antioxidant, anti-inflammatory, anticancer, antiemetic, anxiolytic, antithrombotic, radiation protective, 
antimicrobial, immunostimulant enhancer and appetite stimulant [7,10,11], also inhibiting the 
formation of reactive nitrogen species which are important factors for Alzheimer’s disease [12].  
An overview on patents related to ginger and its components [13] pointed out the potential value of 
ginger products including 1, for pharmaceutical applications. 
In turn, zingerol [4-(4-hydroxy-3-methoxyphenyl)-butan-2-ol] CAS#39728-80-8 (2) is a natural 
non-pungent alcohol [14], isolated as levorrotatory 2R-aglycone from the needles of Taxus baccata L. [15] 
(yield 0.001%) and it is also naturally produced for female sexual attraction (in a non-reported 
stereochemical form) by Bactrocera dorsalis male fly upon consumption of 1 from Bulbophyllum 
flowers [16]. Regarding its heterosides, dextrorotatory 4-O-glucoside was isolated from  
Oxytropis myriophylla [17] in which the C-2 absolute configuration is not reported and, recently,  
4-O-glucoside with 2S-aglycone, namely bumaldoside C, was isolated from Staphylea bumalda [18]. 
Rac-2 demonstrated to be an inhibitor of colonic motility in rats, being suggested as an oral or 
suppository medicine for treating diarrhea and other intestinal disorders [14]. It has been also claimed 
as a component of mixtures containing caffeic, chlorogenic or ferulic acids for preventing, improving 
or treating hypertension [19]. In addition, 2 (of unspecified C-2 absolute configuration) was  
disclosed in different patents as an oral mucosa stimulating component of a formula of a throat  
care agent [20,21]. Rac-2 has also demonstrated to be a useful substrate for the stereoselective 
spiroannulation to asymmetric oxaspiro compounds (diastereoisomeric ratios not over 65/35), that are 
useful starting materials for the asymmetric synthesis of manumycin-type natural products [22]. 
Ketone 1 was previously obtained from dehydrozingerone [(E)-4-(4-hydroxy-3-methoxyphenyl) 
but-3-en-2-one] CAS#1080-12-2 (3), by catalytic hydrogenation of the double bond with H2/Raney Ni [23] 
or H2/Pd-C [24]. 
In turn, previous attempts to synthesize chiral (S)- and (R)-2 led only to the (S)-enantiomer in low 
yields and variable ee, suggesting that the hydrogen was transferred by the ketone re-face, following 
the Prelog’s rule [25]. So, (S)-(+)-2 was previously obtained as a minor by-product (15%, 98% ee) in 
the asymmetric reduction of 1 to 4'-O- or 2-O-glucosides with cultured cells of Phytolacca americana [26] 
Int. J. Mol. Sci. 2014, 15 22044 
 
 
and by biotransformation of 1 with baker’s yeast (45%, 65% ee) [15]. In contrast, a route to (R)-2 has 
not been described yet, except in the work of Kitayama et al. [27] who claimed that (R)-2 was obtained 
along with (S)-2 by kinetic resolution of rac-2 through lipase-catalyzed transesterifications. However, 
those transesterifications did not lead to free (R)-2 but to its acetate. Then, free chiral (R)-2 was 
obtained by hydrolysis of the acetate, but the whole reaction involved three steps: (i) reduction of  
1 with sodium borohydride to give rac-2; (ii) lipase-transesterification of rac-2 to its chiral (R)-acetate; 
(iii) hydrolysis of the (R)-acetate to give free (R)-2 (6%–53% overall yields and 70%–99% ee). 
In this paper we present a biocatalytic route to obtain “natural” 1 and both (R)- and (S)-2 in only 
one step from 3 through biotransformation with filamentous fungi. The predominant driving forces for 
selecting this fungal panel were that some of these fungi have previously given rise to bio-reduction 
products that have the opposite stereochemistry to the predicted by Prelog [28], or have demonstrated 
enoate-reductase ability in our previous works [29]. 
It is worth taking into account that the production of (R)- and (S)-2 could constitute a great advance 
in the pharmaceutical as well as in the synthetic fields since all applications reported for 2 were 
referred to rac-2, that is easily obtained by borohydride reduction of 1 [30]. Since the biological 
activity differences between enantiomers are well-known [31,32], a simple, inexpensive and clean 
mode of production of both forms of chiral 2 will be of great importance to differentiate their 
biological activities. In order to provide a proof of the behavior differences of both enantiomers, here 
we present the antifungal activity of (R)- and (S)-2 against a panel of clinically important fungi with 
standardized methodologies. 
2. Results 
2.1. Fungal Biotransformation of 3 
Dehydrozingerone (3), a natural α,β-unsaturated ketone previously isolated from Z. officinale [33], 
was submitted to fungal biotransformation with the panel of filamentous fungi listed in Table 1, by 
using growing cells methodology [34]. The possible biotransformation products of 3 depend on the 
activity of two enzymes, enoate-reductase (ER) that would lead to the saturated ketone 1 and alcohol 
dehydrogenase (ADH) that would reduce the carbonyl group leading to the saturated alcohol 2 or the 
allylic alcohol (4) (Scheme 1). 
2.2. Biotransformation of 3 with the Whole Fungal Panel 
The GC-MS analysis of the biotransformation crude products showed that, after 72 h (Table 1), 
Aspergillus flavus, Aspergillus fumigatus, Aspergillus niger, Cunninghamella echinulata, Geotrichum 
candidum, Mucor circinelloides, Penicillium citrinum, Rhizopus oryzae and Trichosporum cutaneum 
produced an almost complete substrate consumption (98%–99% conversion rates) while  
Fusarium graminearum got a modest 51% (Table 1). The two new-formed compounds have mass 
fragmentations with molecular peaks of [M]+ 194 and 196, respectively, and proved to be ketone 1  
(Retention Time (RT) = 6.95 min in GC-MS) and the saturated alcohol 2 (RT = 7.09 min). No allylic 
alcohol 4 (RT = 7.47 min) was generated in the biotransformations (Scheme 1). To know the RT of 4,  
we synthesized this allylic alcohol as reported in Materials and Methods and submitted it to GC-MS  
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in the same conditions as the rest of compounds and the biotransformation products. The non-appearance 
of allylic alcohol was also observed by Fronza et al. in the biotransformation of the closely related 
structure 4-(4-hydroxyphenyl)-but-3-en-2-one with baker’s yeast [35]. 
Table 1. Biotransformation of dehydrozingerone 3. Products distribution (in %) of 
zingerone 1 and chiral zingerol 2 after fed with 3 at 0.5 mg/mL with filamentous fungi. 
Absolute configuration, optical rotations (α) and enantiomeric excess of 2 are included.  
Entries Fungal spp. 
Conversion 
Rate (%) 
1 
(%) 
2 
(%)
Absolute 
Configuration 
[α]25 D   
(0.75, CHCl3) 
ee (%) 
1 A. flavus >99 26 74 S +3.1 ± 0.2 20 
2 A. fumigatus >99 90 10 S +2.3 ± 0.4 14 
3 A. niger  99 1 98 R −15.5 ± 0.7 94 
4 C. echinulata >99 1 99 S +11.3 ± 0.7 70 
5 F. graminearum 51 50 1 R −11.8 ± 0.4 72 
6 G. candidum 98 84 14 R −16.1 ± 0.5 98 
7 M. circinelloides >99 1 99 R −10.4 ± 0.7 64 
8 P. citrinum. >99 2 98 S +11.7 ± 0.8 94 
9 R. oryzae >99 81 19 S +14.2 ± 0.4 88 
10 T. cutaneum >99 57 43 R −4.6 ± 0.3 28 
A. flavus: Aspergillus flavus ATCC 9170; A. fumigatus: Aspergillus fumigatus ATCC 26934; A. niger: 
Aspergillus niger ATCC 9029; C. echinulata: Cunninghamella echinulata CCC 164; F. graminearum: 
Fusarium graminearum CCC 170; G. candidum: Geotrichum candidum CCC 116; M circinelloides:  
Mucor circinelloides CCC 128; P. citrinum: Penicillium citrinum CCC 129; R. oryzae: Rhizopus oryzae CCC 
130; T. cutaneum: Trichosporum cutaneum CCC 133. 
Scheme 1. Possible products in the biotransformation of dehydrozingerone 3. * Chiral carbon. 
 
Table 1 shows the products distribution at 72 h (% of 1 and 2) after each biotransformation 
procedure (columns 4 and 5). In this Table the absolute configuration, optical rotations (α) and 
enantiomeric excess of 2 (discussed in Section 2.4) were included.  
A. fumigatus, G. candidum and R. oryzae selectively produced 1 in 81%–90% at 72 h while  
A. flavus, A. niger, C. echinulata, M. circinelloides and P. citrinum selectively produced 2 in 74%–99% 
at 72 h. T. cutaneum was the only fungus that produced 1 and 2 in similar amounts (57% and 43%, 
respectively). For the sake of clarity, Figure 1 shows the results of the biotransformation of 3 at 72 h 
with different filamentous fungi in a bar graph. 
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Figure 1. Biotransformation of dehydrozingerone 3 with ten different filamentous fungi 
during 72 h. The percentages (%) of each product zingerone 1 or zingerol 2 are showed in 
different rows. The front row shows the percentage of the remainder substrate 3 in each 
biotransformation process. 
 
2.3. Time-Course of the Biotransformation of 3 with Selected Fungi 
The course of the reduction of 3 was followed during 72 h, for two selected fungi representative 
each one of those that produced predominantly 1 (A. fumigatus) or 2 (A. niger). An aliquot of 10 mL 
was extracted every 4 h from the culture with EtOAc and the extract was analyzed by GC-MS (Figure 2). 
It is clear that the time-courses of the reactions with both fungi have the common feature that, at 
about 8 h, 3 was almost completely consumed, and 1 was produced as the result of ER activity. 
Figure 2. Time-course of the biotransformation of dehydrozingerone 3 with A. fumigatus 
(A) and A. niger (B). * Chiral carbon. 
 
However, each time-course continues in a quite different way after 8 h. At 72 h, saturated ketone 1 
showed to be the major biotransformation product (90%) with A. fumigatus (Figure 2A) being  
2 produced in only 10%, evidencing a very low ADH activity for this fungus. In contrast, A. niger 
gradually reduced, after 8 h, the whole amount of ketone 1 to 2 (Figure 2B) being 2 at 72 h almost the 
only product (98%), thus indicating that both enzymes ER + ADH are present in this fungus and they 
act one after other. 
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2.4. Absolute Configuration of the Obtained Alcohols 2 
Although the absolute configuration and the ee could be calculated from the optical rotations of  
(R)-2 reported in the literature [15,27], both previous papers differ in the values of optical rotations. 
So, we decided to corroborate the absolute configuration and determine the ee of our biotransformation 
products by preparing rac-2 by NaBH4 reduction of 1 and observing the 1H NMR spectral differences 
of the diastereomeric esters formed with the (S)-α-methoxy-α-trifluoromethylphenyl acetic acid 
(MTPA) and each (R)-2 and (S)-2 enantiomeric alcohols of the racemic mixture. Results showed that 
methyl protons of (R)-2 esterified with (S)-MTPA appear as doublets at lower fields (1.36 ppm) than 
those of (S)-2 (1.29 ppm) (Figure 3) because the methyl protons of the (S)-form are shielded by the 
phenyl group of (S)-MTPA (Figure 4). 
Figure 3. 1H NMR spectra of (S)-(−)-MTPA esters with: (A) a mixture enriched with the 
alcohol (R)-2 obtained by biotransformation of 3 with A. niger; (B) a mixture enriched 
with the alcohol (S)-2 obtained by biotransformation of 3 with P. citrinum; and (C) rac-2. 
 
Figure 4. Configuration correlation model for (S)-MTPA esters of (R)-2 (A) and (S)-2 (B). 
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The enantiomeric excess (% ee) of the products was determined with chiral HPLC, by using a 
Chiralcel OD-H column. Figure 5 shows HPLC profiles of rac-2 (Figure 5A), and of the products enriched 
in (R)- or (S)-2 obtained by biotransformation with A. niger (Figure 5B) and P. citrinum (Figure 5C). The 
retention times (RT) for each enantiomer (R)- and (S)-2 were 15.7 and 18.7 min, respectively. 
Figure 5. Chromatograms obtained by chiral HPLC of rac-2 (A); (R)-2, Retention Time 
(RT) = 15.7 min (B) and (S)-2; RT = 18.7 min (C). 
 
Through this methodology, we could corroborate the stereochemistry of all obtained alcohols and 
determine the ee (Table 1). Among the five fungi (A. flavus, A. niger, C. echinulata, M. circinelloides 
and P. citrinum) that selectively produce 2, A. flavus, C. echinulata and P. citrinum produced mainly 
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(S)-(+)-2 with 20%, 70% and 94% ee, respectively. Instead, A. niger and M. circinelloides gave the 
levorotatory (R)-(−)-2 with 94% and 64% ee, respectively. 
2.5. Antifungal Activity of (S)-, (R)- and rac-2 
Considering that the stereochemistry of chiral compounds often play an important role in the 
antimicrobial activity [36], we tested (R)- and (S)-2 against a panel of clinically important fungi, 
comprising the yeasts Candida albicans, Saccharomyces cerevisiae and Cryptococcus neoformans and 
the dermatophytes Microsporum gypseum, Trichophyton rubrum and Trichophyton mentagrophytes 
(Figure 6). For testing, we chose (S)-2 with 94% ee and (R)-2 with 98% ee (Table 1). The minimum 
concentration that inhibited fungal growth (MIC) was investigated following the guidelines of Clinical 
and Laboratory Standards Institute (CLSI) [37,38]. 
Figure 6. Comparative antifungal activities of (S)- (94% ee) and (R)-zingerol  
(98% ee) against yeasts and filamentous fungi. Ca: Candida albicans ATCC 10231;  
Sc: Saccharomyces cerevisiae ATCC 9763; Cn: Cryptococcus neoformans ATCC 32264; 
Mg: Microsporum gypseum CCC 115; Tr: Trichophyton rubrum CCC 110;  
Tm: Trichophyton mentagrophytes ATCC 9972. MICs of terbinafine against Mg, Tr and 
Tm = 0.04, 0.01 and 0.04 µg/mL, respectively. MICs of Amphotericin B against Ca, Sc and 
Cn = 1.00, 0.50 and 0.25 µg/mL, respectively. 
 
Results showed that (S)-2 was completely devoid of activity up to 1000 µg/mL. Instead, (R)-2 
possessed antifungal activity against C. albicans, S. cerevisiae and C. neoformans with MIC  
values = 125 µg/mL and against the dermatophytes M. gypseum, T. rubrum and T. mentagrophytes 
with MICs = 62.5 µg/mL. 
3. Discussion 
In this work, the α,β-unsaturated ketone 3 was used as the substrate of biotransformation to obtain 1 
and both chiral forms of 2, mainly of (R)-2. Neither the substrate 3 nor filamentous fungi have been 
previously used to obtain chiral 2. 
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The selective reduction of each the carbonyl group or/and the double bond can be achieved in 
compounds containing two reducible functional groups, such as the α,β-unsaturated ketone 3, 
depending whether the biocatalyst possesses ER or ADH enzyme or both [28]. The presence of both 
enzymes could be a bottleneck in the biotransformations with whole cells, because they can act one 
after other in two steps in which the product of the first reaction is the substrate for the second activity 
or, instead, one can compete with the other, sometimes preventing the generation of the desired 
product or/and the stereoselectivity of the reaction as it was previously reported [35,39–41]. 
Interesting enough, the biotransformation of 3 with A. fumigatus, G. candidum and R. oryzae  
gave selectively 1 at 72 h with 81%–90% strongly suggesting that these fungi possess a high ER but 
modest ADH activities. In addition, the time-course of the reaction with A. niger suggests that the 
bioconversion with this fungus and also with A. flavus, C. echinulata, M. circinelloides and P. citrinum 
would allow the production of 1 as the sole product if the reaction is stopped at short times. 
In turn, the biotransformation of 3 with A. flavus, A. niger, C. echinulata, M. circinelloides and  
P. citrinum produced 2 at 72 h in 74%–99%, showing that these fungi possess both ER and ADH 
enzymes, although ADH acts after ER. However, different enantioselectivities were obtained with each 
fungus. A. niger and M. circinelloides reduced the carbonyl group in the anti-Prelog sense giving (R)-(−)-2. 
Of them A. niger was the most efficient catalyst in terms of alcohol 2 yield and ee (98% yield and 94% ee). 
According to our knowledge, this is the first report on filamentous fungi (or any microorganism) able 
to produce (R)-2 with good yields and high ee in only one step-biotransformation procedure. 
Instead, A. flavus, C. echinulata and P. citrinum reduced the carbonyl group in the Prelog sense 
producing (S)-(+)-2, being P. citrinum the best biocatalyst with alcohol 2 yield = 98% and ee = 94%. 
The antifungal properties of both chiral forms of 2 against a panel of clinically important fungi 
showed that (R)-, but not (S)-2, possessed antifungal activity, mainly active against dermatophytes. 
These fungi are responsible for approximately the 80%–93% of chronic, recurrent and hardly 
eradicable skin infections in human beings and are the ethiological agents of tinea unguium (producer 
of invasive nail infections), Tinea manuum (palmar and interdigital areas of the hand infections) and 
Tinea pedis (Athlete’s foot), the last one being the most prevalent fungal infection in developed 
countries, and the first one accounting for 50% and 90% of all fingernail and toenail infections, 
respectively [42]. 
Although the antifungal activity of (R)-2 is moderate, the great difference in activity between both 
enantiomers of 2 provides a clear proof on the relevance of having achieved an easy and inexpensive 
route to the production of this alcohol, in high conversion rates and ee. In the synthetic field, the 
spiroannulation of each enantiomer of 2 will allow a more efficient production of asymmetric oxaspiro 
compounds that are useful starting materials for the asymmetric synthesis of manumycin-type natural 
products [22]. 
4. Experimental Section 
4.1. General Considerations 
Solvents and reagents were purchased from Sigma (St. Louis, MO, USA) and were purified 
according to standard procedures. 1H and 13C NMR spectra were recorded on a Bruker Avance-300 
DPX spectrometer (Karlsruhe, Germany). Compounds were dissolved in deuterated solvents from 
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commercial sources (Sigma) using tetramethylsilane (TMS) as internal standard. Chemical shifts are 
reported in ppm (δ) relative to the solvent peak (CHCl3 in CDCl3 at 7.26 ppm for protons and at 77.0 ppm 
for carbons). Signals are designated as follows: s, singlet; d, doublet; dd, doublet of doublets; m, multiplet. 
Gas chromatograms were obtained in a CG-MS Shimadzu QP-2010 plus (Shimadzu, Kyoto, Japan), 
column SPB-1 30 m × 0.25 mm of inner diameter, film 0.25 μm, ionization energy 70 eV. 
Optical rotations were measured in a Jasco DIP-1000 digital polarimeter (Easton, MD, USA). The 
reported data refer to the Na-line value (589 nm). IR spectra were recorded using an IR Prestige-21 Fourier 
Transform Infrared Spectrophotometer (Shimadzu, Kyoto, Japan). HPLC analyses were performed 
with a chromatograph Varian ProStar (San Diego, CA, USA) equipped with UV-V detector ProStar 
320 at 254 nm, using a Chiralcel OD-H, 25 cm column. Hexane (Hex) and isopropanol HPLC grade 
were used as eluents in a mixture 92:8. Flow rate was 0.8 mL/min. 
4.2. Preparation of 3 
A NaOH aq solution (20%, 50 mL) was added to a solution of vanillin (Sigma) (10.0 g, 65.7 mmol) 
in acetone (60 mL), and the mixture was stirred overnight [43]. Then, the mixture was diluted with 
cold distilled water and acidified with cc HCl (70 mL) leading to a yellow precipitate, which was 
filtered and purified by Silica gel column chromatography by using a mixture of Hex and EtOAc (9:1) 
as eluent. Pure 3 (10.6 g, 84%) was obtained as a colorless solid, mp 126–127 °C. Spectroscopic data 
were in agreement with those previously described [43–45]. IR νmax/cm−1 (film) 3352, 1587, 1257.  
1H NMR (CDCl3; 300 MHz): δ 2.37 (3H, s, 1-H); 3.93 (3H, s, OMe); 5.94 (1H, s, 4’-OH); 6.59 (1H, d, 
J = 16.2 Hz, H-3); 6.93 (1H, d, J = 8.1 Hz, H-5’); 7.06 (1H, d, J = 1.9 Hz, H-2'); 7.09 (1H, dd, J = 8.1; 
1.9 Hz, H-6'); 7.45 (1H, d, J = 16.2 Hz, H-4). 13C NMR (CDCl3; 75 MHz): δ 27.3 (1-Me); 56.0 (7'-OMe); 
109.3 (C-2'); 114.8 (C-5'); 123.5 (C-6'); 125.0 (C-3); 126.9 (C-1'); 143.7 (C-4); 146.9 (C-4'); 148.3  
(C-3'); 198.4 (C=O). GC:RT = 7.74 min. EI-MS m/z 192 [M+]. 
4.3. Fungal Strains Used for Biotransformation 
The filamentous fungi A. flavus ATCC 9170; A. fumigatus ATCC 26934; A. niger ATCC 9029;  
C. echinulata CCC 164; F. graminearum CCC 170; G. candidum CCC 116; M. circinelloides CCC 
128; P. citrinum CCC 129; R. oryzae CCC 130 and T. cutaneum CCC 133 were obtained from either 
the American Type Culture Collection (ATCC) (Manassas, VA, USA) or the Culture Collection of 
Reference Center on Mycology (CCC, School of Biochemical and Pharmaceutical Sciences, Suipacha 
531-(2000)-Rosario, Argentina). Fungi were grown on agarized Czapeck (for Aspergillus spp.)  
or Sabouraud culture medium (for the rest of fungal strains) for 3 days at 30 °C until well-sporulated. 
Each fungus inoculum suspension was prepared with conidia taken from the culture surface and 
adjusted to 2–5 × 106 CFU/mL, according to reported procedures [37]. 
4.4. Biotransformation Methodology  
In two-liter erlenmeyer-flasks containing Czapek or Sabouraud broth medium (1 L), fungal 
inoculum (1 mL) was added and the mixture was incubated at 30 °C for 72 h with shaking on an 
Innova 4000 orbital shaker New Brunswick Scientific (Edison, NJ, USA) at 150 rpm [34]. A solution 
of 3 (100 mg) in DMSO (5 mL) was added to one of the flasks (bioconversion flask) and instead,  
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5 mL of pure DMSO was poured in the other one (fungal growth control flask). A third flask (substrate 
control flask), containing culture medium and substrate (fungal-free) was prepared. The three flasks 
were incubated with stirring (150 rpm) at 30 °C for 72 h. After incubation, mixtures were filtered  
and aqueous phases were bulked and extracted with EtOAc (3 × 250 mL). Organic phases were dried 
over Na2SO4. 
4.5. Analysis of the Product Mixtures with GC-MS 
The products were analyzed by GC-MS using a Shimadzu QP-2010 plus chromatograph 
(Shimadzu, Kyoto, Japan), equipped with a fused silica gel column (SPB-1 30 m × 0.25 mm ID) with 
He as a carrier gas at a flow rate of 1.0 mL/min, coupled to a mass selective detector, 0.25 µm film, and  
an ionization energy of 70 eV with a temperature program of 50–300 °C at 25 °C/min; total time 13 min. 
The conversion rates were determined by using the following equation: [Conversion % = (product 
TIC/product TIC + substrate) × 100] (TIC = total ion current). The product mixtures were purified by 
PTLC with silica gel GF254 (Merck, Buenos Aires, Argentina) by using a mixture of Hex:EtOAc (1:1) 
as eluent. The structure of each product was elucidated by 1H NMR, 13C NMR and MS and the spectra 
were compared with the literature. 
4.6. Preparation of MTPA Esters of (R)-, (S)- and rac-2 
Chiral alcohol 2 and rac-2 were converted into MTPA esters with (S)-(−)-MTPA  
[as its (R)-(−)-MTPA-Cl] (Sigma) following reported procedures [46]. The reaction mixture was 
shaken and allowed to stand 12 h at room temperature (rt). Then, 3-dimethylamino-1-propylamine 
(DMAPA) was added in excess and the mixture was allowed to stand for 5 min before being diluted 
with diethyl ether. The organic solution was washed with cold 1 N HCl (2 mL), cold saturated Na2CO3 
solution (2 mL) and brine (2 mL), dried (MgSO4) and concentrated to dryness. The residue was 
analyzed by 1H NMR (CDCl3) [47]. 
4.7. Synthesis of Ketone 1 for Comparative Purposes 
To a stirred solution of 3 (5 g) in EtOAc (30 mL), Pd/C (10%) was added and the mixture was 
stirred 4 h under H2 atmosphere (1 atm) at rt. The reaction mixture was filtered, washed with EtOAc 
and evaporated under vacuum giving a crude product which was purified by column chromatography 
using Hex:EtOAc (8:2) as eluent to obtain 1 (4.2 g, 83%) as a colorless solid, mp 40–42 °C [48]. 
Spectroscopic data of 1 were in good agreement with those previously described [49]. IR νmax/cm–1 
(film) 3408, 1708, 1271. 1H NMR (CDCl3; 300 MHz): δ 2.15 (3H, s, H-1); 2.79 (4H, m, H-3, H-4); 
3.88 (3H, s, 3'-OMe); 5.59 (1H, s, 4'-OH); 6.69 (2H, m, H-2' and H-6'); 6.84 (1H, d, J = 8.1 Hz,  
H-5'); 13C NMR (CDCl3; 75 MHz): δ 29.5 (C-4); 30.1 (CH3); 45.5 (C-3); 55.1 (3'-OCH3); 111.1 (C-2'); 
114.4 (C-5'); 120.7 (C-6'); 132.9 (C-1'); 143.9 (C-4'); 146.4 (C-3'); 208.3 (C=O). GC:RT = 6.95 min. 
EI-MS m/z 194 [M+]. 
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4.8. Synthesis of rac-(±)-2 for Comparative Purposes 
NaBH4 (23 mg, 0.6 mmol) was added in small portions to a stirred, cooled (0 °C) solution of 1 (38 mg, 
0.2 mmol) in MeOH (3 mL) [15]. The mixture was stirred 3 h at 0 °C and 1 h at rt. Water and a few 
drops of cc HCl were then added and the mixture was extracted with Et2O (3 × 5 mL). The combined 
Et2O extracts were washed with saturated aq NaHCO3 and water, dried (Na2SO4) decanted and 
evaporated to dryness yielding 35.3 mg (89%) of a solid from which pure (±)-2 was obtained by 
preparative TLC [plates with Si gel 60 GF254 (Merck, Argentina) using a mixture of hexane (Hex) and 
EtOAc (7:3) as eluent]. IR νmax/cm−1 (film), 3340, 1271. 1H NMR (CDCl3; 300 MHz): δ 1.23 (3H, d,  
J = 6.2 Hz, CH3); 1.74 (2H, m, H-3); 2.63 (2H, m, H-4); 3.83 (1H, m, H-2); 3.88 (3H, s, 3'-OMe);  
6.72 (1H, dd, J = 8.0 and 1.8 Hz, H-6'); 6.78 (1H, d, J = 1.8 Hz, H-2'); 7.05 (1H, d, J = 8.0 Hz, H-5'); 
13C NMR (CDCl3; 75 MHz): δ 20.2 (CH3); 31.2 (C-3); 38.6 (C-4); 55.8 (3'-OCH3); 68.7 (C-2);  
110.0 (C-2'); 114.3 (C-5'); 120.9 (C-6'); 133.7 (C-1'); 143.7 (C-4'); 146.4 (C-3'). GC:RT = 7.09 min. 
EI-MS m/z 196 [M+]. 
4.9. Synthesis of Allylic Alcohol 4 for Comparative Purposes 
The α-enone 3 (168 mg, 0.87 mmol) and CeCl3·7H2O (326 mg, 0.87 mmol) were dissolved in 4 mL 
of MeOH. NaBH4 (29 mg, 0.75 mmol) was added in one portion, with stirring (30 min) [50]. Stirring 
was continued for a few minutes (3–5 min) before the pH was adjusted to neutrality with dilute 
aqueous HCl, the mixture was extracted (ether) and dried (Na2SO4), and the solvent evaporated. The 
crude residue was analyzed for NMR and GC-MS. It was then purified by column chromatography and 
identified by the usual spectroscopic methods and comparison with authentic samples. 1H NMR 
(CDCl3; 300 MHz): δ 1.26 (3H, d, J = 6.5 Hz, CH3); 3.86 (3H, s, 3'-OMe); 4.37 (1H, m, H-2); 6.14 
(1H, dd, J = 15.5 and 6.0 Hz, H-3); 6.45 (1H, d, J = 15.5 Hz, H-4); 6.76 (1H, d, J = 8.0 Hz, H-5'); 6.84 
(1H, dd, J = 8.0 and 2.0 Hz, H-6'); 7.04 (1H, d, J = 2.0 Hz, H-2'); 13C NMR (CDCl3; 75 MHz): δ 23.3 
(CH3); 56.0 (3'-OCH3); 68.5 (C-2); 110.1 (C-2'); 115.7 (C-5'); 120.4 (C-6'); 129.1 (C-4); 129.9 (C-1'); 
132.1 (C-3); 146.7 (C-4'); 148.3 (C-3'). GC:RT = 7.47 min. EI-MS m/z 194 [M+]. 
4.10. Chiral-HPLC Analyses  
A Varian ProStar chromatograph equipped with UV-V detector ProStar 320 at 254 nm, and a 25 cm 
Chiralcel OD-H column was used for analyzing the biotransformation products containing chiral 2  
and synthetic rac-2. Hex and isopropanol HPLC-grade (88:12) were used as eluent. Flow rate was  
0.8 mL/min, with retention times of 15.7 and 18.7 min for (R)- or (S)-enantiomer, respectively. 
4.11. Antifungal Evaluation 
4.11.1. Microorganisms and Media 
For the antifungal evaluation, standardized strains from the American Type Culture Collection 
(ATCC), Rockville, MD, USA, and Culture Collection of Reference Center of Mycology (CCC), Faculty 
of Biochemical and Pharmaceutical Sciences, Suipacha 531-(2000)-Rosario, Argentina were used:  
C. albicans ATCC 10231, S. cerevisiae ATCC 9763, C. neoformans ATCC 32264, T. rubrum  
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CCC 110, T. mentagrophytes ATCC 9972 and M. gypseum CCC 115. Strains were grown on  
Sabouraud-chloramphenicol agar slants for 48 h at 30 °C, maintained on slopes of Sabouraud-dextrose 
agar (SDA, Oxoid, Hampshire, UK) and sub-cultured every 15 days to prevent pleomorphic 
transformations. Inocula of cell or spore suspensions were obtained according to reported  
procedures [37,38] and adjusted to 1–5 ×103 cells/spores with colony forming units (CFU)/mL. 
4.11.2. Antifungal Susceptibility Testing 
Minimum Inhibitory Concentration (MIC) of each compound was determined by using broth 
microdilution techniques according to the guidelines of CLSI for yeasts and for filamentous  
fungi [37,38]. The culture medium was RPMI-1640 (Sigma) buffered to pH 7.0 with MOPS (Remel 
Inc., Lenexa, KS, USA). For the assay, stock solutions of pure compounds were two-fold diluted with 
RPMI from 1000 to 0.98 µg/mL (final volume = 100 µL) and a final DMSO concentration ≤1%.  
A volume of 100 µL of inoculum suspension was added to each well with the exception of the sterility 
control where sterile water was added to the well instead. Terbinafine and amphotericin B were used as 
positive controls. Microtiter trays were incubated at 35 °C for yeasts and at 28–30 °C for the rest of 
fungi in a moist, dark chamber. MIC, which was defined as the lowest concentration of drug resulting 
in total inhibition of visual growth compared to the growth in the control wells, were visually recorded 
at 48 h for yeasts, and at a time according to the control fungus growth, for the rest of fungi. 
Compounds with MICs ≥ 1000 µg/mL were considered inactive. 
5. Conclusions 
We report here an efficient, clean, inexpensive and “natural” way to obtain the flavoring agent  
1 from 3 by biotransformation with filamentous fungi and, in addition, we were able to produce (R)-2 
for the first time in only one bioconversion step in high conversion rates and ee. This work also 
provides a new alternative to produce (S)-2 with filamentous fungi. Regarding biological activities, 
(R)- but not (S)-2 showed antifungal activities against clinically important fungi, adding a new proof 
on the differences in biological behavior of enantiomers. These findings can also constitute an important 
alternative in the synthetic processes in which rac-2 was used [22]. 
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